Top Markets
Coin of the day
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
Rangering i aksjer #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
Aksjekurs
$0.0003
Sist synkronisert: 2023-06-13
Markedsverdi
$28.14K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Neuropathix, Inc. (NPTX)

Kategori

Antall utestående aksjer for Neuropathix, Inc. (NPTX)
Antall utestående aksjer per August 2026: 0
Ifølge Neuropathix, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Neuropathix, Inc. (NPTX) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE